K Number
K994167
Date Cleared
2000-03-07

(89 days)

Product Code
Regulation Number
892.1200
Panel
RA
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

To obtain attenuation corrected Positron Emission Tomography (PET) images, by a Gamma Camera.

Device Description

The CoDe AC attenuation correction system is an addition to the Apex VariCam and Millennium VG gamma cameras (K953801). It comprises additional hardware and software to generate corrected Positron Emission Tomography images for non-uniform attenuation.

AI/ML Overview

Here's a breakdown of the acceptance criteria and study information for the CoDe AC: Attenuation Correction System, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The provided text does not explicitly state specific quantitative acceptance criteria (e.g., a specific percentage improvement, a threshold for artifact reduction). However, the overarching acceptance criterion is demonstrating substantial equivalence to the predicate device, VTransACT option for the Apex VariCam (K980659), in terms of safety and effectiveness.

Acceptance Criteria CategorySpecific Metric (Implied)Acceptance Threshold (Implied)Reported Device Performance
Image UniformityDegree of uniformity in PET images after attenuation correctionNo significant difference compared to predicateDelivers more uniform images than regular coincidence imaging without attenuation correction. Comparison to VTransACT images shows no significant difference.
SafetyNo new safety concerns raisedAdherence to existing safety standards for similar devices and design featuresSealed and shielded source, manually activated, no electro-mechanical shutter, self-powered LED, well-collimated, integral part of septa collimator.
Effectiveness (General)Ability to produce attenuation-corrected PET imagesSubstantially equivalent to predicateStated as substantially equivalent to the VTransACT option.

2. Sample Size Used for the Test Set and Data Provenance

  • Sample Size for Test Set: Not explicitly stated. The document mentions "Bench data and Clinical data" were used, but no specific number of cases or patients is given for the clinical data.
  • Data Provenance: Not explicitly stated. However, the manufacturer is ELGEMS Ltd., located in Tirat Hacarmel, Israel, suggesting the data may have originated from Israel. It is not specified if the data was retrospective or prospective.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This information is not provided in the document.

4. Adjudication Method for the Test Set

This information is not provided in the document.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study and Effect Size

  • Was an MRMC study done? It is not explicitly stated that an MRMC comparative effectiveness study was performed. The phrasing "Comparison to VTransACT images shows no significant difference" suggests a comparison, but not necessarily with human readers involved or an MRMC design.
  • Effect size of human reader improvement: This is not applicable as an MRMC study with human readers assessing improvement with human-AI assistance is not mentioned. The device's primary function is to correct images, not to directly assist human interpretation in a comparative effectiveness study of the AI system itself.

6. Standalone (Algorithm Only) Performance

  • Was a standalone performance study done? Yes, implicitly. The statement "Bench data and Clinical data show that the CoDe AC option for the VariCam delivers more uniform images than regular coincidence imaging system without attenuation correction. Comparison to VTransACT images shows no significant difference" refers to the performance of the device's algorithm in generating corrected images. It is assessing the algorithm's output directly.

7. Type of Ground Truth Used

The ground truth used for image uniformity and attenuation correction is implicitly based on:

  • Comparison to a legally marketed predicate device (VTransACT): The "no significant difference" claim implies that the VTransACT's corrected images served as a de-facto "ground truth" or a benchmark for acceptable performance.
  • Improvement over uncorrected images: The statement "delivers more uniform images than regular coincidence imaging system without attenuation correction" suggests that the physical reality of non-uniform attenuation and its correction served as the ground truth against which uniformity was assessed. This would likely involve phantom studies (bench data) where the true attenuation is known or controlled.

8. Sample Size for the Training Set

This information is not provided in the document.

9. How the Ground Truth for the Training Set Was Established

This information is not provided in the document. Given the nature of an attenuation correction system (a signal processing and image reconstruction task), the "training" might involve developing algorithms to correct known physical phenomena rather than training on a large dataset with expert-labeled ground truth in the same way an AI diagnostic system would. However, the document does not elaborate on the development or training process.

§ 892.1200 Emission computed tomography system.

(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.